Last reviewed · How we verify
Vaccination with FAB-3511 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Vaccination with FAB-3511 (Vaccination with FAB-3511) — Fluart Innovative Vaccine Ltd, Hungary.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vaccination with FAB-3511 TARGET | Vaccination with FAB-3511 | Fluart Innovative Vaccine Ltd, Hungary | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vaccination with FAB-3511 CI watch — RSS
- Vaccination with FAB-3511 CI watch — Atom
- Vaccination with FAB-3511 CI watch — JSON
- Vaccination with FAB-3511 alone — RSS
Cite this brief
Drug Landscape (2026). Vaccination with FAB-3511 — Competitive Intelligence Brief. https://druglandscape.com/ci/vaccination-with-fab-3511. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab